focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.
Been here too long bud,
He should be banned.. Just use the new reporting system by LSE for reporting any of his P i s h.
I think he has lets say "Special" issues to be honest.. More to be felt sorry for to be honest. I hvae him filtered so dont know what ****e he posts other than what other posters note.
Don't think it will be long till we hear positive news here guys.. We just need a sniff that this is going to market and we are off to the races..
GL All
Frits.
Looks a tempting offer. So after having a look at the numbers and potential news, have jumped on board with a
few k.
Good luck all, has the potential to make some money.
Oil is looking positive for the coming months.
GL All
Frits
Quote from the article -
" Our findings with the therapeutic P140 peptide already used in lupus support the view that down-regulating excessive autophagy could improve patient outcomes by reducing neuronal inflammation"
Not long now till we get positive news that will drive this back to a more realistic share price.
Have a good weekend all.
Frits
It's just a matter of time. The P140 compound has a proven and positive background and won't be shelved. THIS WIlL go to market in some shape or form. I heard that the local village idiot Nobinurlips was asking me something. I have him filtered as he has mental health issues and I don't feed in to them. Just hold the course guys. Just a matter of time. Frits
Why do you all entertain Nobinurlips? The pric.k is not even invested in IMM! He is a complete tool with no job or money to invest in the market. He posts as if he is an invested here when in reality he's is a complete freaking fruit loop. What reason does he have to even comment here? It's like me going to the RBS BB and spouting she.ite when I am not even invested there, I would only do it if I had some issues with my napper and was a VI.. He is total work shy kno.b Don't encourage him by replying to his pish. Frits
In my opinion, I am absolutely positive that this is going to go to market, either by IMM or a Big Pharma takeover Quote Tim McCarthy "The really significant data we�ve put just now is that in the European group, those patients who presented with this positive antibody showed a superior response and actually statistically significance response over the placebo and that is important, clearly. We didn�t see the same result in the US and that could be due to a number of factors, not least that the proportion of patients presenting with the antibody was a lot lower at 40% and the numbers themselves in terms of the number of patients was a lot lower." Big Pharma will be looking in to this new data update and examining it thoroughly. Remember, it did not fail the trial. It just did not meet the end point. However, the end point was met in Europe. This is the important point to note from the data review. Quote "The really significant data we�ve put just now is that in the European group, those patients who presented with this positive antibody showed a superior response and actually statistically significance response over the placebo and that is important. Have patients guys... Just a matter of time.. GLA Frits
That's me now fully loaded guys. Looking positive here.. For some reason my trade did not show up! No surprise there.. 2 great RNS today. Just wait on the media presentation starting and other investors getting back in.. There is too much progress been made here regards Lupus.. Its just a matter of tweaking the medication. P140 is a brand new pharmacological platform and will need some adjusting. But once its been tweaked, the potential here is absolutely massive. THere is no way that this will be shelved and the Big Pharmas know that. Well done to all the long term holders and good luck to new investors to IMM. As I have always said, its just a matter of time. Data analysis is not black or white, there is a lot of grey. But the proof is in the pudding as they say. GL All Frits.
Only one aspect of the trial failed which was the end point. It failed due to poor organisation during the set up of the parameters. Nothing more.. Nothing Less. The remainder of the study which covered many different facets were a success. This is clinical research. its not black or white.. These studies are grey. The end point is used as general reference point and is open to interpretation. Frits